These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1396330)

  • 21. Effects of thyroid and glucocorticoid hormones on the level of messenger ribonucleic acid for iodothyronine type I 5'-deiodinase in rat primary hepatocyte cultures grown as spheroids.
    Menjo M; Murata Y; Fujii T; Nimura Y; Seo H
    Endocrinology; 1993 Dec; 133(6):2984-90. PubMed ID: 8243326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of chicken hepatic type I and type III iodothyronine deiodinases during embryonic development.
    Van der Geyten S; Sanders JP; Kaptein E; Darras VM; Kühn ER; Leonard JL; Visser TJ
    Endocrinology; 1997 Dec; 138(12):5144-52. PubMed ID: 9389494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutation of the Secys residue 266 in human type 2 selenodeiodinase alters 75Se incorporation without affecting its biochemical properties.
    Salvatore D; Harney JW; Larsen PR
    Biochimie; 1999 May; 81(5):535-8. PubMed ID: 10403186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pretranslational regulation of type I 5'-deiodinase by thyroid hormones and in fasted and diabetic rats.
    O'Mara BA; Dittrich W; Lauterio TJ; St Germain DL
    Endocrinology; 1993 Oct; 133(4):1715-23. PubMed ID: 8404614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of a propylthiouracil-insensitive type I iodothyronine deiodinase.
    Sanders JP; Van der Geyten S; Kaptein E; Darras VM; Kühn ER; Leonard JL; Visser TJ
    Endocrinology; 1997 Dec; 138(12):5153-60. PubMed ID: 9389495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of recombinant membrane-bound type I iodothyronine deiodinase in yeast.
    Kuiper GG; Klootwijk W; Visser TJ
    J Mol Endocrinol; 2005 Jun; 34(3):865-78. PubMed ID: 15956354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 3,5-diiodo-L-thyronine stimulates type 1 5'deiodinase activity in rat anterior pituitaries in vivo and in reaggregate cultures and GH3 cells in vitro.
    Baur A; Bauer K; Jarry H; Köhrle J
    Endocrinology; 1997 Aug; 138(8):3242-8. PubMed ID: 9231774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ligand-induced inactivation of type I iodothyronine 5'-deiodinase: protection by propylthiouracil in vivo and reversibility in vitro.
    St Germain DL; Croteau W
    Endocrinology; 1989 Nov; 125(5):2735-44. PubMed ID: 2792006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular biological and biochemical characterization of the human type 2 selenodeiodinase.
    Salvatore D; Bartha T; Harney JW; Larsen PR
    Endocrinology; 1996 Aug; 137(8):3308-15. PubMed ID: 8754756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Substrate-induced down-regulation of human type 2 deiodinase (hD2) is mediated through proteasomal degradation and requires interaction with the enzyme's active center.
    Steinsapir J; Bianco AC; Buettner C; Harney J; Larsen PR
    Endocrinology; 2000 Mar; 141(3):1127-35. PubMed ID: 10698189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selenium-regulated translation control of heterologous gene expression: normal function of selenocysteine-substituted gene products.
    Leonard JL; Leonard DM; Shen Q; Farwell AP; Newburger PE
    J Cell Biochem; 1996 Jun; 61(3):410-9. PubMed ID: 8761945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Iodothyronine deiodinase activities in FRTL5 cells: predominance of type I 5'-deiodinase.
    Borges M; Ingbar SH; Silva JE
    Endocrinology; 1990 Jun; 126(6):3059-68. PubMed ID: 2351108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crystal structure of mammalian selenocysteine-dependent iodothyronine deiodinase suggests a peroxiredoxin-like catalytic mechanism.
    Schweizer U; Schlicker C; Braun D; Köhrle J; Steegborn C
    Proc Natl Acad Sci U S A; 2014 Jul; 111(29):10526-31. PubMed ID: 25002520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deiodination of iodothyronine sulfamates by type I iodothyronine deiodinase of rat liver.
    Rutgers M; Heusdens FA; Visser TJ
    Endocrinology; 1991 Sep; 129(3):1375-81. PubMed ID: 1874177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of type I iodothyronine 5'-deiodinase as a selenoenzyme.
    Behne D; Kyriakopoulos A; Meinhold H; Köhrle J
    Biochem Biophys Res Commun; 1990 Dec; 173(3):1143-9. PubMed ID: 2268318
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The mRNA structure has potent regulatory effects on type 2 iodothyronine deiodinase expression.
    Gereben B; Kollár A; Harney JW; Larsen PR
    Mol Endocrinol; 2002 Jul; 16(7):1667-79. PubMed ID: 12089359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid stimulation of type I 5'-deiodinase in rat pituitaries by 3,3',5-triiodo-L-thyronine.
    Köhrle J; Schomburg L; Drescher S; Fekete E; Bauer K
    Mol Cell Endocrinol; 1995 Feb; 108(1-2):17-21. PubMed ID: 7758832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The 3'-untranslated region of human type 2 iodothyronine deiodinase mRNA contains a functional selenocysteine insertion sequence element.
    Buettner C; Harney JW; Larsen PR
    J Biol Chem; 1998 Dec; 273(50):33374-8. PubMed ID: 9837913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure-activity relationships for thyroid hormone deiodination by mammalian type I iodothyronine deiodinases.
    Toyoda N; Kaptein E; Berry MJ; Harney JW; Larsen PR; Visser TJ
    Endocrinology; 1997 Jan; 138(1):213-9. PubMed ID: 8977406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selenocysteine, a highly specific component of certain enzymes, is incorporated by a UGA-directed co-translational mechanism.
    Böck A; Stadtman TC
    Biofactors; 1988 Oct; 1(3):245-50. PubMed ID: 2978458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.